Skip to main content

Home/ healthcare regulation and scandals/ Group items tagged regulation

Rss Feed Group items tagged

Brett Snodgrass

in-Training Medical Education (#MedEd) Forum * Medstro - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Risk factors for triple-negative breast cancer in women under the age of 45 years. - Pu... - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Rapid Progression of Basal-Type Breast Cancer - NEJM - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Dr Social - Breast Cancer Fiasco Maybe only for ER PR - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Comparing Assays for Estrogen and Progesterone Receptors: Materials and Methods - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Comparing Assays for Estrogen and Progesterone Receptors: Results - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

H&R Block®-2013 Unallowed Expenses and Losses - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Dr Social - Mishler v Arizona Medical Board 3919 - 0 views

  • t Dr. Mishler, and that complaint was subsequently found to be unjustified, the Board purposely scrutinized Dr. Mishler's charts to find evidence with which to discipline Dr. Mishler.
  • Board used its own rules of confidentiality as an excuse to obstruct Dr. Mishler's access to evidence, it violated the same policy with respect to Dr. Mishler's confidential reports.
  •  
    In 1993 Dr. Mishler, a neurosurgeon was forced to go to court against the Arizona Board of Medical Examiners secondary to their unscrupulous and unethical conduct. The Arizona Medical Board obstructed peer
Brett Snodgrass

Mishler v. State Bd. of Med. Examiners, 849 P. 2d 291 - Nev: Supreme Court 1993 - 0 views

  • When we look beyond the label of the discipline given to Dr. Mishler to the true nature of the facts, we conclude that the discipline was unwarranted. The Board's power was not exercised for the proper and commendable purpose of protecting 297*297 the public from incompetent and negligent physicians. Instead, the Board wielded its power to ruin the career of an outspoken physician while simultaneously protecting a possibly negligent or incompetent practitioner who had questionable billing procedures.
  • In short, we conclude that the Board's actions and the proceedings against Dr. Mishler constituted a disturbing abuse of its power.
  • Therefore, we reverse the disciplinary order of the Board in its entirety and dismiss all proceedings against Dr. Mishler with prejudice.
  •  
    In 1993, the Arizona Supreme Court overturned all the of the AZ Medical Board's claims v. Dr. Mishler with prejudice. The Board's actions against Dr. Mishler constituted a disturbing abuse of its power.
Brett Snodgrass

Mathews v. Lancaster General Hosp., 87 F. 3d 624 - Court of Appeals, 3rd Circuit 1996 -... - 0 views

  • Dr. Robert Mathews
  • He practices as a corporate partner with anothe
  • George Kent.
  • ...4 more annotations...
  • Dr. Kent was performing spinal surgery at Lancaster General. Dr. Mathews was listed as a co-surgeon for the operation. During the procedure, a high speed drill slipped and tore the patient's esophagus.
  • 27 of the 208
  • Mr. Robert Katana, President and CEO of Columbia Hospital, discovered the application did not contain a reappointment reference from Lancaster Genera
  • unity from 632*632 monetary damages under § 11111(a) of the Health Care Quality Improvement Act. The district court also granted summary judgmen
  •  
    Interesting and complex case. Surgical privileges at hospitals vary markedly from most other physician privileges
Brett Snodgrass

Dr Social - Should i be concerned??? - 0 views

  •  
    Healthcare scandals along with the related relevant medical and scientific literature highlighting why the actions are considered a scandal. Regulatory medicine, healthcare, health policy, and patient safety. Doctor Brett Snodgrass, MD has a particular interest in transparency in healthcare and policy suggestions that regulators can consider in order to prevent things such as the VA Scandal, the UMKC Pathology Breast Cancer Scandal of 2011, and many others including the Stem Cell Scandal of South Korea in 2006.
Brett Snodgrass

Breast Cancer Scandal of 2011 - 0 views

  •  
    The 2011 UMKC Pathology Breast Cancer Scandal was a cover-up of the prolonged, unsafe, ischemic times provided to women with breast cancer in the UMKC-TMC Pathology Department. Reports of unsafe patient care went neglected by the pathology chair, an attending, the residents, the DIO. I reported this to the ACGME in 2011 and in 2014 I discovered that the UMKC-Graduate Medical Education office lied to the ACGME about months of breast cancer care.
Brett Snodgrass

The Prognostic Value of Documented Unprofessional Behavior in Medical School Records fo... - 0 views

  • The link between unprofessional behavior in medical school and board action is too weak to be of any prognostic valu
  • board action is not a good criterion for validating unprofessional behavior in medical school as an indicator of later problems in practice.
  • quality of research reporting
  • ...1 more annotation...
  • medical education
  •  
    The quality of research about medical education is too low to be used to make assertions about the quality of patient care.
aarkstore1

Gastric Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 - 0 views

  •  
    Emerging Phase III products for Gastric Ulcers 2019 - report provides comprehensive insights about marketed and Phase III products for Gastric Ulcers - https://www.aarkstore.com/pharmaceuticals-healthcare/768519/gastric-ulcers-global-api-manufacturers-marketed-and-phase-iii-drugs-landscape-2018
« First ‹ Previous 61 - 74 of 74
Showing 20 items per page